Geneos Wealth Management Inc. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 3 filers reported holding TG THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,536
-66.3%
4230.0%0.00%
-100.0%
Q2 2023$10,507
+65.2%
4230.0%0.00%
Q1 2023$6,362
-40.2%
423
-53.0%
0.00%
-100.0%
Q4 2022$10,6479000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders